WTO Exemptions To Give Leg-Up To Bangladeshi, Indian Firms?

The WTO Council's recent decision to grant least-developed country members an exemption from implementing intellectual property provisions, such as patents, on medicines is expected to give Bangladesh's up-and-coming pharma industry valuable buffer time to catch up with and possibly take on rivals in the region.

A 17-year extension on implementing intellectual property (IP) provisions that has been granted to least-developed countries (LDCs) by the World Trade Organization Council, some experts say, could allow pharma firms in Bangladesh to catch up with some of their regional rivals.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from India

More from Focus On Asia